162 related articles for article (PubMed ID: 32079093)
21. Chitosan functionalized PCL nanoparticles bearing tyrosine kinase inhibitor osimertinib mesylate for effective lung cancer therapy.
Dhuri A; Sriram A; Aalhate M; Mahajan S; Parida KK; Singh H; Gupta U; Maji I; Guru SK; Singh PK
Pharm Dev Technol; 2023 Jun; 28(5):460-478. PubMed ID: 37092801
[TBL] [Abstract][Full Text] [Related]
22. Thiolated Chitosan Masked Polymeric Microspheres with Incorporated Mesocellular Silica Foam (MCF) for Intranasal Delivery of Paliperidone.
Nanaki S; Tseklima M; Christodoulou E; Triantafyllidis K; Kostoglou M; Bikiaris DN
Polymers (Basel); 2017 Nov; 9(11):. PubMed ID: 30965919
[TBL] [Abstract][Full Text] [Related]
23. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
[TBL] [Abstract][Full Text] [Related]
24. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
Luo Y; Teng Z; Li Y; Wang Q
Carbohydr Polym; 2015 May; 122():221-9. PubMed ID: 25817662
[TBL] [Abstract][Full Text] [Related]
25. Development of anti-HER2-targeted doxorubicin-core-shell chitosan nanoparticles for the treatment of human breast cancer.
Naruphontjirakul P; Viravaidya-Pasuwat K
Int J Nanomedicine; 2019; 14():4105-4121. PubMed ID: 31239670
[No Abstract] [Full Text] [Related]
26. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
[TBL] [Abstract][Full Text] [Related]
27. Controlled release of silica-coated insulin-loaded chitosan nanoparticles as a promising oral administration system.
Fathy MM; Hassan AA; Elsayed AA; Fahmy HM
BMC Pharmacol Toxicol; 2023 Mar; 24(1):21. PubMed ID: 36998008
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
[TBL] [Abstract][Full Text] [Related]
29. Influence of chitosan coating on magnetic nanoparticles in endothelial cells and acute tissue biodistribution.
Agotegaray M; Campelo A; Zysler R; Gumilar F; Bras C; Minetti A; Massheimer V; Lassalle V
J Biomater Sci Polym Ed; 2016 Aug; 27(11):1069-85. PubMed ID: 27251857
[TBL] [Abstract][Full Text] [Related]
30. Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages.
Grabowski N; Hillaireau H; Vergnaud J; Tsapis N; Pallardy M; Kerdine-Römer S; Fattal E
Int J Pharm; 2015 Mar; 482(1-2):75-83. PubMed ID: 25448553
[TBL] [Abstract][Full Text] [Related]
31. Drug-free chitosan coated poly(isobutylcyanoacrylate) nanoparticles are active against trichomonas vaginalis and non-toxic towards pig vaginal mucosa.
Pradines B; Bories C; Vauthier C; Ponchel G; Loiseau PM; Bouchemal K
Pharm Res; 2015 Apr; 32(4):1229-36. PubMed ID: 25319099
[TBL] [Abstract][Full Text] [Related]
32. The characteristics of betamethasone-loaded chitosan microparticles by spray-drying method.
Huang YC; Yeh MK; Cheng SN; Chiang CH
J Microencapsul; 2003; 20(4):459-72. PubMed ID: 12851046
[TBL] [Abstract][Full Text] [Related]
33. Formulation and Evaluation of Atorvastatin Calcium-Poly-ε-Caprolactone Nanoparticles Loaded Ocular Inserts for Sustained Release and Antiinflammatory Efficacy.
Girgis GNS
Curr Pharm Biotechnol; 2020; 21(15):1688-1698. PubMed ID: 32427080
[TBL] [Abstract][Full Text] [Related]
34. Chitosan-Coated Azithromycin/Ciprofloxacin-Loaded Polycaprolactone Nanoparticles: A Characterization and Potency Study.
Yassin AE; Albekairy AM; Omer ME; Almutairi A; Alotaibi Y; Althuwaini S; Alaql OA; Almozaai SS; Almutiri NM; Alluhaim W; Alzahrani RR; Alterawi AM; Halwani MA
Nanotechnol Sci Appl; 2023; 16():59-72. PubMed ID: 38146545
[TBL] [Abstract][Full Text] [Related]
35. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats.
Sonaje K; Italia JL; Sharma G; Bhardwaj V; Tikoo K; Kumar MN
Pharm Res; 2007 May; 24(5):899-908. PubMed ID: 17377747
[TBL] [Abstract][Full Text] [Related]
36. Core-shell Pluronic F127/chitosan based nanoparticles for effective delivery of methotrexate in the management of rheumatoid arthritis.
Shafiq A; Madni A; Khan S; Sultana H; Sumaira ; Shah H; Khan S; Rehman S; Nawaz M
Int J Biol Macromol; 2022 Jul; 213():465-477. PubMed ID: 35661673
[TBL] [Abstract][Full Text] [Related]
37. Lornoxicam-Loaded Chitosan-Decorated Nanoemulsion: Preparation and In Vitro Evaluation for Enhanced Transdermal Delivery.
Khan RU; Shah SU; Rashid SA; Naseem F; Shah KU; Farid A; Hakeem KR; Kamli MR; Althubaiti EH; Alamoudi SA
Polymers (Basel); 2022 May; 14(9):. PubMed ID: 35567091
[TBL] [Abstract][Full Text] [Related]
38. Ecotoxicity evaluation of polymeric nanoparticles loaded with ascorbic acid for fish nutrition in aquaculture.
Luis AIS; Campos EVR; Oliveira JL; Vallim JH; Proença PLF; Castanha RF; de Castro VLSS; Fraceto LF
J Nanobiotechnology; 2021 May; 19(1):163. PubMed ID: 34059056
[TBL] [Abstract][Full Text] [Related]
39. Prolonged retention and in vivo evaluation of cationic nanoparticles loaded with Mitomycin C designed for intravesical chemotherapy of bladder tumours.
Erdoğar N; Iskit AB; Mungan NA; Bilensoy E
J Microencapsul; 2012; 29(6):576-82. PubMed ID: 22468630
[TBL] [Abstract][Full Text] [Related]
40. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study.
Hosseinzadeh H; Atyabi F; Dinarvand R; Ostad SN
Int J Nanomedicine; 2012; 7():1851-63. PubMed ID: 22605934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
